| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8507909 | Acta Pharmaceutica Sinica B | 2018 | 11 Pages |
Abstract
This review talks about basic strategies of inflammation-targeting biomimetic nanoparticles, which includes i) synthetic nanoparticles modified with targeting ligands that mimic cell surface proteins; ii) cell membrane-coated nanoparticles; iii) liposomes engineered with cell membrane proteins.217
Keywords
Apolipoprotein E knockout micePNPCcl5LFA-1VCAM-1SPIOVLA-4Cy7CD40LGPVIPSGL-1GPIbαglycoprotein IbαPECAM-1CXCR1LLVDSPE-PEGSLexTargeting ligandsPLA-PEGCXCL4TGF-βcluster of differentiation 40 ligandGPVCell membrane proteinsHUVECPLGARBCLPSIBDCTCIgGCTLvWFICAM-1sialyl Lewis XRheumatoid arthritisMRIimmunoglobulin GinterleukinInflammatory bowel diseaseTransforming growth factor βMagnetic resonance imagingMolecular imagingtumor necrosis factor-αvery late antigen-4CAMTh cellDendritic cellImmune cellsVon Willebrand factorLymphocyte function associated antigen-1Cell membraneTNF-αlipopolysaccharideP-selectin glycoprotein ligand-1major histocompatibility complexMHCcellular adhesion moleculevascular cellular adhesion molecule-1Mac-1poly(lactic-co-glycolic acid)chemokine (C-C motif) ligand 5circulating tumor cellred blood cellglycoprotein VI
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Kai Jin, Zimiao Luo, Bo Zhang, Zhiqing Pang,